Shares of Osiris Therapeutics Inc. (NASDAQ:OSIR) rose 3% during mid-day trading on Friday . The stock traded as high as $5.15 and last traded at $5.10, with a volume of 64,866 shares changing hands. The stock had previously closed at $4.95.

Separately, Zacks Investment Research downgraded Osiris Therapeutics from a “hold” rating to a “sell” rating in a report on Tuesday, March 29th.

The company has a market capitalization of $175.71 million and a PE ratio of 121.43. The stock’s 50 day moving average is $5.06 and its 200 day moving average is $6.17.

An institutional investor recently raised its position in Osiris Therapeutics stock. GSA Capital Partners LLP boosted its position in Osiris Therapeutics Inc. (NASDAQ:OSIR) by 10.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 98,901 shares of the company’s stock after buying an additional 9,702 shares during the period. GSA Capital Partners LLP owned 0.29% of Osiris Therapeutics worth $1,027,000 as of its most recent filing with the SEC.

Osiris Therapeutics, Inc is a medical products company. The Company is focused on developing and marketing products in regenerative medicine, including bioengineering, stem cell research and viable tissue based products. The Company’s offers products in orthopedics, sports medicine and wound care, including Cartiform, BIO4 and Grafix.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.